Go Pro

Dudley & Shanley Inc. Raises Holdings in Xylem Inc. $XYL

Xylem logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Dudley & Shanley Inc. more than doubled its Xylem stake in the second quarter, increasing holdings by 124% to 181,050 shares valued at approximately $21.4 million. Institutional investors collectively own 87.96% of Xylem.
  • Analysts maintain a generally positive view, with nine Buy ratings and six Holds, producing a “Moderate Buy” consensus and an average price target of $154, above the stock’s reported $120.36 opening price.
  • Xylem exceeded quarterly earnings expectations, reporting $1.46 in EPS versus a $1.34 estimate, while revenue rose 1.5% year over year to $2.34 billion. The company also pays a quarterly dividend of $0.43, equivalent to a 1.4% annual yield.
  • MarketBeat previews the top five stocks to own by September 1st.

Dudley & Shanley Inc. increased its position in Xylem Inc. (NYSE:XYL - Free Report) by 124.0% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 181,050 shares of the industrial products company's stock after acquiring an additional 100,220 shares during the quarter. Xylem comprises 3.2% of Dudley & Shanley Inc.'s investment portfolio, making the stock its 17th largest holding. Dudley & Shanley Inc. owned approximately 0.08% of Xylem worth $21,402,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wexford Capital LP purchased a new position in Xylem in the 3rd quarter valued at approximately $27,000. Commonwealth Retirement Investments LLC purchased a new position in shares of Xylem in the fourth quarter valued at $27,000. Global Assets Advisory LLC purchased a new stake in Xylem during the 1st quarter worth about $40,000. FWL Investment Management LLC bought a new position in Xylem in the 2nd quarter worth about $43,000. Finally, Entrust Financial LLC purchased a new position in Xylem during the 4th quarter valued at about $45,000. Institutional investors own 87.96% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Mizuho raised their price objective on shares of Xylem from $124.00 to $130.00 and gave the company a "neutral" rating in a research report on Wednesday, July 29th. Citigroup reiterated a "buy" rating on shares of Xylem in a research report on Wednesday, July 29th. UBS Group boosted their target price on Xylem from $129.00 to $135.00 and gave the stock a "neutral" rating in a research report on Thursday, July 30th. Barclays raised their price target on Xylem from $154.00 to $159.00 and gave the company an "overweight" rating in a report on Wednesday, July 29th. Finally, JPMorgan Chase & Co. cut their price objective on Xylem from $170.00 to $160.00 and set an "overweight" rating for the company in a report on Thursday, April 16th. Nine research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat.com, Xylem has an average rating of "Moderate Buy" and a consensus target price of $154.00.

Check Out Our Latest Stock Report on XYL

Xylem Price Performance

Shares of Xylem stock opened at $120.36 on Monday. The firm has a market capitalization of $28.10 billion, a PE ratio of 28.66, a price-to-earnings-growth ratio of 1.67 and a beta of 1.02. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The business's 50-day moving average price is $116.32 and its 200-day moving average price is $121.21.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.12. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business had revenue of $2.34 billion during the quarter, compared to analyst estimates of $2.34 billion. During the same quarter in the prior year, the firm earned $1.26 earnings per share. Xylem's revenue for the quarter was up 1.5% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Sell-side analysts forecast that Xylem Inc. will post 5.67 EPS for the current fiscal year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. Xylem's dividend payout ratio is 40.95%.

Xylem Profile

(Free Report)

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Read More

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines